CD1 is a membrane protein with structural and functional similarities to the MHC molecules, restricting presentation of hydrophobic or lipid antigens to T cells or NK T cells. Unlike the MHC class I and II molecules, CD1 acts as a restricting factor in a nonpolymorphic manner. Altered lipid metabolisms occur in atherosclerosis, leading to accumulation of chemically modified lipids in the arterial wall where T lymphocytes and macrophages are accumulating. It is likely that the immune cells are exposed to the atherogenic lipid antigens and become activated. Preliminary data from our studies on cultured cells have shown that treatment with certain lipids can induce expression of CD1 in vascular smooth muscle cells. This raises the possibility that CD1-positive smooth muscle cells may behave like dendritic cells and present lipid antigens to CD1-restricted T cells during the development of atherosclerosis. The central hypothesis is that loading with atherogenic lipids can enhance expression of CD1 proteins in the progenitors of vascular smooth muscle cells (SMC), which in turn act as antigen presenting cells capable of presenting the lipid antigens to T or NK T cells.
Specific Aim 1 is to determine whether expression of CD1 is associated with differentiation of embryonic stem cells into vascular SMC;
Specific Aim 2 to determine whether cytokines or growth factors such as interleukin-4 and monocyte colony stimulating factor (M-CSF) can synergize with lipids to induce expression of CD1 in vascular SMC progenitors as well as mature adult SMC;
Specific Aim 3 to determine whether CD1 positive, lipid-loaded human SMC progenitors or ESC-derived SMC present CD1-restricted lipid antigens to T or NK T cells. Human embryonic stem cell lines will be used to generate SMC progenitors and produce stable cell lines which over-express CD1. Unique 3D culture system and T cell-human ESC/SMC co-cultures will be established. Fulfillment of the above objectives will provide novel mechanisms by which lipid antigens activate immune cells and cause inflammation in the arteries with atherosclerosis. ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
3R01HL069509-03S1
Application #
6744661
Study Section
Special Emphasis Panel (ZRG1-CDF-5 (50))
Program Officer
Rabadan-Diehl, Cristina
Project Start
2001-09-30
Project End
2005-07-31
Budget Start
2003-08-01
Budget End
2004-07-31
Support Year
3
Fiscal Year
2003
Total Cost
$74,271
Indirect Cost
Name
University of Texas Health Science Center Houston
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800771594
City
Houston
State
TX
Country
United States
Zip Code
77225
Jiang, Xue-Yan; Feng, Yu-Liang; Ye, Li-Tong et al. (2017) Inhibition of Gata4 and Tbx5 by Nicotine-Mediated DNA Methylation in Myocardial Differentiation. Stem Cell Reports 8:290-304
Rosales, Corina; Tang, Daming; Geng, Yong-Jian (2015) CD1d serves as a surface receptor for oxidized cholesterol induction of peroxisome proliferator-activated receptor-?. Atherosclerosis 239:224-31
Gao, Song; Wassler, Michael; Zhang, Lulu et al. (2014) MicroRNA-133a regulates insulin-like growth factor-1 receptor expression and vascular smooth muscle cell proliferation in murine atherosclerosis. Atherosclerosis 232:171-9
Madonna, Rosalinda; Geng, Yong-Jian; Bolli, Roberto et al. (2014) Co-activation of nuclear factor-?B and myocardin/serum response factor conveys the hypertrophy signal of high insulin levels in cardiac myoblasts. J Biol Chem 289:19585-98
Li, Yangxin; Shelat, Harnath; Wu, Hanjing et al. (2014) Low circulating level of IGF-1 is a distinct indicator for the development of cardiovascular disease caused by combined hyperglycemia and dyslipidemia. Int J Cardiol 171:272-3
Madonna, R; Wu, H; Shelat, H et al. (2013) CD1d-associated expression of NF-kB and cardiac dysfunction in diabetic and obese mice. Int J Immunopathol Pharmacol 26:59-73
Li, Yangxin; Yang, Chen-Min; Xi, Yutao et al. (2013) MicroRNA-1/133 targeted dysfunction of potassium channels KCNE1 and KCNQ1 in human cardiac progenitor cells with simulated hyperglycemia. Int J Cardiol 167:1076-8
Madonna, Rosalinda; Taylor, Doris A; Geng, Yong-Jian et al. (2013) Transplantation of mesenchymal cells rejuvenated by the overexpression of telomerase and myocardin promotes revascularization and tissue repair in a murine model of hindlimb ischemia. Circ Res 113:902-14
Li, Yangxin; Shen, Zhenya; Shelat, Harnath et al. (2013) Reprogramming somatic cells to pluripotency: a fresh look at Yamanaka's model. Cell Cycle 12:3594-8
Madonna, Rosalinda; Wu, Danli; Wassler, Michael et al. (2013) Myocardin-A enhances expression of promyogenic genes without depressing telomerase activity in adipose tissue-derived mesenchymal stem cells. Int J Cardiol 167:2912-21

Showing the most recent 10 out of 36 publications